Business Description
AegirBio AB
ISIN : SE0014401121
Share Class Description:
AEGBF: Ordinary SharesCompare
Compare
Traded in other countries / regions
AEGIR.Sweden52Q.GermanyAEGBF.USA IPO Date
2023-04-18Description
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -0.21 | |||||
Debt-to-Equity | -3.52 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -17.63 | |||||
Beneish M-Score | -11.51 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -25.8 | |||||
3-Year EPS without NRI Growth Rate | -29.7 | |||||
3-Year FCF Growth Rate | -36.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -36.09 | |||||
12-1 Month Momentum % | -36.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.02 | |||||
Days Sales Outstanding | 49737.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.4 | |||||
Shareholder Yield % | -178.84 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 355.56 | |||||
Operating Margin % | -138108.33 | |||||
Net Margin % | -137155.56 | |||||
FCF Margin % | -130400 | |||||
ROE % | -221.77 | |||||
ROA % | -64.79 | |||||
ROIC % | -84.16 | |||||
ROC (Joel Greenblatt) % | -2005.36 | |||||
ROCE % | -59.24 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 275 | |||||
EV-to-EBIT | -0.96 | |||||
EV-to-EBITDA | -0.96 | |||||
EV-to-Revenue | 1043.42 | |||||
EV-to-FCF | -0.79 | |||||
Earnings Yield (Greenblatt) % | -104.17 | |||||
FCF Yield % | -278.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:AEGBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AegirBio AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.003 | ||
EPS (TTM) ($) | -0.196 | ||
Beta | 0 | ||
Volatility % | 36.09 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.11 | ||
12-1 Month Momentum % | -36.09 | ||
52-Week Range ($) | 0.11 - 0.17211 | ||
Shares Outstanding (Mil) | 30.88 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AegirBio AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AegirBio AB Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
AegirBio AB Frequently Asked Questions
What is AegirBio AB(AEGBF)'s stock price today?
The current price of AEGBF is $0.11. The 52 week high of AEGBF is $0.17 and 52 week low is $0.11.
When is next earnings date of AegirBio AB(AEGBF)?
The next earnings date of AegirBio AB(AEGBF) is 2024-08-23.
Does AegirBio AB(AEGBF) pay dividends? If so, how much?
AegirBio AB(AEGBF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |